# Study of SOM0226 in Familial Amyloid Polyneuropathy

> **NCT02191826** · PHASE1,PHASE2 · COMPLETED · sponsor: **SOM Innovation Biotech SA** · enrollment: 17 (actual)

## Conditions studied

- Familial Amyloid Polyneuropathy (FAP)

## Interventions

- **DRUG:** SOM0226

## Key facts

- **NCT ID:** NCT02191826
- **Lead sponsor:** SOM Innovation Biotech SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2016-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02191826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02191826, "Study of SOM0226 in Familial Amyloid Polyneuropathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02191826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*